Smith & Nephew SNATS Total Assets 2006-2018 | SNN

Smith & Nephew SNATS total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Smith & Nephew SNATS total assets for the quarter ending December 31, 2018 were $7.866B, a 9.02% increase year-over-year.
  • Smith & Nephew SNATS total assets for 2018 were $8.059B, a 2.45% increase from 2017.
  • Smith & Nephew SNATS total assets for 2017 were $7.866B, a 7.11% increase from 2016.
  • Smith & Nephew SNATS total assets for 2016 were $7.344B, a 2.47% increase from 2015.
Smith & Nephew SNATS Annual Total Assets
(Millions of US $)
2018 $8,059
2017 $7,866
2016 $7,344
2015 $7,167
2014 $7,306
2013 $5,819
2012 $5,642
2011 $4,747
2010 $4,733
2009 $4,565
2008 $4,508
2007 $4,450
2006 $3,231
2005 $3,194
Smith & Nephew SNATS Quarterly Total Assets
(Millions of US $)
Q4 2017 $7,866
Q2 2017 $7,439
Q4 2016 $7,344
Q4 2015 $7,167
Q2 2015 $7,215
Q4 2014 $7,306
Q3 2014 $7,650
Q2 2014 $7,742
Q1 2014 $5,940
Q4 2013 $5,819
Q3 2013 $5,567
Q2 2013 $5,452
Q1 2013 $5,465
Q4 2012 $5,642
Q3 2012 $4,997
Q2 2012 $4,812
Q1 2012 $4,884
Q4 2011 $4,747
Q3 2011 $4,821
Q2 2011 $4,909
Q1 2011 $4,790
Q4 2010 $4,733
Q3 2010 $4,878
Q2 2010 $4,583
Q1 2010 $4,535
Q4 2009 $4,565
Q3 2009 $4,627
Q2 2009 $4,517
Q1 2009 $4,306
Q4 2008 $4,508
Q3 2008 $4,525
Q2 2008 $4,709
Q1 2008 $4,671
Q4 2007 $4,450
Q3 2007 $4,276
Q2 2007 $4,233
Q1 2007 $3,217
Q4 2006 $3,231
Q3 2006 $3,202
Q2 2006 $3,163
Q1 2006 $3,099
Q4 2005 $3,194
Q3 2005 $2,978
Q2 2005 $3,088
Q1 2005 $3,026
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $19.113B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.296B 28.49
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
Baxter (BAX) United States $42.165B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.194B 48.74
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.254B 51.05
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Quidel (QDEL) United States $2.261B 23.46
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00